Similarly, without the APOE ε4 or ε2 dosage weights, the AD PHS was not associated with the presence of at least limbic (transitional) LB pathology (OR 1.04 95% CI [0.89–1.22]). The gene discussed is APOE; the disease is Alzheimer disease.